Insights on the Robust Variance Estimator under Recurrent‐Events Model
Summary Recurrent events are common in medical research for subjects who are followed for the duration of a study. For example, cardiovascular patients with an implantable cardioverter defibrillator (ICD) experience recurrent arrhythmic events that are terminated
by shocks or antitachycardia pacing delivered by the device. In a published randomized clinical trial, a recurrent‐event model was used to study the effect of a drug therapy in subjects with ICDs, who were experiencing recurrent symptomatic arrhythmic events. Under this model, one expects
the robust variance for the estimated treatment effect to diminish when the duration of the trial is extended, due to the additional events observed. However, as shown in this article, that is not always the case. We investigate this phenomenon using large datasets from this arrhythmia trial
and from a diabetes study, with some analytical results, as well as through simulations. Some insights are also provided on existing sample size formulae using our results.
No Supplementary Data
No Article Media
Document Type: Research Article
Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina 27705, U.S.A.
Department of Statistics, Virginia Tech, Blacksburg, Virginia 24060, U.S.A.
Department of Biostatistics, University of Washington, Seattle, Washington 98195, U.S.A.
Section of Biostatistics, Mayo Clinic, Rochester, Minnesota 55905, U.S.A.
Publication date: 01 December 2011